...
首页> 外文期刊>Journal of Neurology, Neurosurgery and Psychiatry >Absence of evidence for the effectiveness of five interventions routinely used in the intensive care management of severe head injury: a systematic review (see comments)
【24h】

Absence of evidence for the effectiveness of five interventions routinely used in the intensive care management of severe head injury: a systematic review (see comments)

机译:尚无证据证明重度颅脑损伤的重症监护管理中常规采用的五种干预措施的有效性:系统评价(请参阅评论)

获取原文
获取原文并翻译 | 示例

摘要

OBJECTIVES: To assess the effectiveness of interventions routinely used in the intensive care management of severe head injury, specifically, the effectiveness of hyperventilation, mannitol, CSF drainage, barbiturates, and corticosteroids. METHODS: Systematic review of all unconfounded randomised trials, published or unpublished, that were available by August 1996. RESULTS: None of the interventions has been reliably shown to reduce death or disability after severe head injury. One trial of hyperventilation was identified of 77 participants. The relative risk for death was 0.73 (95% confidence interval (95% CI) 0.36-1.49), and for death or disability it was 1.14 (95% CI 0.82-1.58). One trial of mannitol was identified of 41 participants. The relative risk for death was 1.75 (95% CI 0.48-6.38), no data were available for disability. No randomised trials of CSF drainage were identified. Two randomised trials of barbiturate therapy were identified, including 126 participants. The pooled relative risk for death was 1.12 (95% CI 0.81-1.54). Disability data were available for one trial. The relative risk for death or disability was 0.96 (95% CI 0.62-1.49). Thirteen randomised trials of corticosteroids were identified, comprising 2073 participants. The pooled relative risk for death was 0.95 (0.84 to 1.07) and for death or disability it was 1.01 (95% CI 0.91 to 1.11). On the basis of the currently available randomised evidence, for every intervention studied it is impossible to refute either a moderate increase or a moderate decrease in the risk of death or disability. CONCLUSION: Existing trials have been too small to support or refute the existence of a real benefit from using hyperventilation, mannitol, CSF drainage, barbiturates, or corticosteroids. Further large scale randomised trials of these interventions are required.
机译:目的:评估重症头部重症监护中常规使用的干预措施的有效性,特别是过度换气,甘露醇,脑脊液引流,巴比妥类药物和皮质类固醇的有效性。方法:系统回顾所有在1996年8月之前可用的公开或未发表的无混淆随机试验。结果:没有一项干预措施被可靠地证明可减少严重颅脑损伤后的死亡或残疾。一项通气过度试验被确定为77名参与者。死亡的相对风险是0.73(95%置信区间(95%CI)0.36-1.49),死亡或残疾的相对风险是1.14(95%CI 0.82-1.58)。甘露醇的一项试验被确定为41名参与者。死亡的相对危险度为1.75(95%CI 0.48-6.38),尚无残疾数据。没有确定脑脊液引流的随机试验。确定了两项巴比妥类药物治疗的随机试验,包括126名参与者。合并的相对死亡风险为1.12(95%CI 0.81-1.54)。残疾数据可用于一项试验。死亡或致残的相对风险为0.96(95%CI 0.62-1.49)。确定了13个皮质类固醇随机试验,包括2073名参与者。合并的相对死亡风险为0.95(0.84至1.07),死亡或残疾风险为1.01(95%CI 0.91至1.11)。根据目前可用的随机证据,对于所研究的每种干预措施,均无法驳斥死亡或残疾风险的适度增加或适度降低。结论:现有试验规模太小,无法支持或驳斥使用过度换气,甘露醇,脑脊液引流,巴比妥酸盐或皮质类固醇的真正益处。这些干预措施需要进一步的大规模随机试验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号